Fox Run Management, L.L.C. Astrazeneca PLC Transaction History

Fox Run Management, L.L.C.

$608 Million
Q1 2025

A detailed history of Fox Run Management, L.L.C. transactions in Astrazeneca PLC stock. As of the latest transaction made, Fox Run Management, L.L.C. holds 24,890 shares of AZN stock, worth $1.8 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares

24,890

Previous 22,614 10.06%

Holding current value

$1.8 Million

Previous $1.48 Million 23.5%

% of portfolio

0.3%

Previous 0.28%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	BUY	$65.37 - $77.96 $148,782 - $177,436	2,276 Added 10.06%	24,890 $1.83 Million
Q4 2024 Feb 11, 2025	BUY	$63.2 - $79.58 $1.43 Million - $1.8 Million	22,614 New	22,614 $1.48 Million
Q2 2024 Aug 13, 2024	SELL	$66.81 - $80.83 $76,631 - $92,712	-1,147 Reduced 8.44%	12,445 $970,000
Q1 2024 May 13, 2024	BUY	$61.03 - $69.57 $829,519 - $945,595	13,592 New	13,592 $920,000
Q2 2023 Aug 11, 2023	BUY	$69.91 - $75.81 $708,188 - $767,955	10,130 New	10,130 $725,000
Q4 2022 Feb 07, 2023	BUY	$54.21 - $70.44 $398,660 - $518,015	7,354 New	7,354 $498,000
Q1 2022 May 10, 2022	SELL	$55.72 - $67.12 $271,690 - $327,277	-4,876 Closed	0 $0
Q4 2021 Feb 09, 2022	BUY	$54.02 - $63.83 $263,401 - $311,235	4,876 New	4,876 $284,000
Q4 2019 Feb 14, 2020	SELL	$42.46 - $50.46 $241,257 - $286,713	-5,682 Closed	0 $0
Q3 2019 Oct 15, 2019	BUY	$40.12 - $45.47 $227,961 - $258,360	5,682 New	5,682 $253,000
Q2 2019 Jul 17, 2019	SELL	$37.28 - $41.68 $695,122 - $777,165	-18,646 Closed	0 $0
Q1 2019 Oct 17, 2019	SELL	$35.49 - $43.02 $9,049 - $10,970	-255 Reduced 1.35%	18,646 $754,000
Q4 2018 Jan 15, 2019	BUY	$36.86 - $41.49 $696,690 - $784,202	18,901 New	18,901 $718,000
Q3 2018 Oct 05, 2018	SELL	$34.76 - $39.72 $302,412 - $345,564	-8,700 Closed	0 $0
Q2 2018 Jul 17, 2018	SELL	$34.55 - $37.05 $537,667 - $576,572	-15,562 Reduced 64.14%	8,700 $305,000
Q1 2018 Apr 17, 2018	BUY	$32.97 - $36.63 $799,918 - $888,717	24,262 New	24,262 $848,000
Q4 2017 Jan 18, 2018	SELL	$32.09 - $34.78 $901,729 - $977,318	-28,100 Closed	0 $0
Q3 2017 Oct 23, 2017	BUY	$28.96 - $34.0 $813,776 - $955,400	28,100	28,100 $952,000

Others Institutions Holding AZN

# of Institutions

1,428

Shares Held

504M

Call Options Held

10M

Put Options Held

3.14M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $224B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fox Run Management, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Fox Run Management, L.L.C. with notifications on news.

Account

Fox Run Management, L.L.C. Astrazeneca PLC Transaction History